The National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, is enrolling 2,000 U.S. families in a study to help determine the COVID-19 infection rate in U.S. children and their family members, and the share of infected children who develop symptoms. The families will participate in the study remotely by mailing nasal swab samples for laboratory analysis and completing online questionnaires.

鈥淥ne interesting feature of this novel coronavirus pandemic is that very few children have become sick with COVID-19 compared to adults,鈥 NIAID Director Anthony Fauci, M.D. 鈥淚s this because children are resistant to infection with SARS-CoV-2, or because they are infected but do not develop symptoms?鈥

The researchers also hope to clarify whether people with asthma or other allergic conditions are less susceptible to infection and severe disease, as preliminary evidence suggests.

Related News Articles

Headline
The Food and Drug Administration July 15 announced a recall by Sandoz on certain lots of cefazolin, due to the lots being mislabeled as penicillin G potassium鈥
Headline
 The Food and Drug Administration July 10 approved Moderna鈥檚 Spikevax COVID-19 vaccine for children under 12 with at least one underlying condition that鈥
Headline
The Occupational Safety and Health Administration June 30 released a proposed rule to remove what remains of its emergency temporary standard for occupational鈥
Headline
Department of Health and Human Services Secretary Robert F. Kennedy Jr. May 27 announced in a post on X that the Centers for Disease Control and Prevention鈥
Headline
Leaders of the Food and Drug Administration May 20 announced new guidelines for administering the COVID-19 vaccine in a paper published by the New England鈥
Headline
A study published April 8 by the Public Library of Science鈥檚 Journal of Global Public Health found that driving while infected with COVID-19 raises the risk of鈥